feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / TGA Warns on Diabetes Drug Side Effects

TGA Warns on Diabetes Drug Side Effects

1 Dec, 2025

•

Summary

  • Mental health warnings issued for GLP-1 agonists.
  • Contraception effectiveness may be reduced by Mounjaro.
  • Suicidal thoughts are a potential side effect to monitor.
TGA Warns on Diabetes Drug Side Effects

The Therapeutic Goods Administration (TGA) has introduced critical safety alerts concerning widely used GLP-1 receptor agonist medications, including Ozempic, Wegovy, Saxenda, Trulicity, and Mounjaro. These drugs, primarily prescribed for diabetes and weight management, are now flagged for potential mental health side effects.

Doctors are advised by the TGA to closely monitor patients for any signs of depression, suicidal ideation, or unusual behavioral changes. This proactive measure addresses reported instances of suicidal behavior and ideation associated with this class of drugs, emphasizing the need for careful patient observation.

Furthermore, the TGA issued a specific warning regarding Mounjaro and its impact on contraception. A potential for reduced effectiveness of oral contraceptives has been identified when initiating or increasing Mounjaro dosage. Patients using oral contraceptives are now advised to use non-oral methods or barrier contraception for a period after starting or adjusting Mounjaro.

trending

Islamabad suicide blast kills 31

trending

Ronaldo trains with Al Nassr

trending

India A vs Namibia live

trending

Vaibhav Suryavanshi scores 175

trending

VTU adopts Artificial Super Intelligence

trending

Riyan Parag scores fifty

trending

T20 World Cup opening ceremony

trending

Tiigers Kolkata reach ISPL final

trending

Al Ettifaq favored vs Damac

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The TGA warns of potential suicidal thoughts and mood changes with Ozempic and similar GLP-1 medications.
Yes, the TGA warns Mounjaro may reduce the effectiveness of oral contraceptives, recommending alternative methods.
The TGA has issued warnings for GLP-1 receptor agonists, including Ozempic, Wegovy, Saxenda, Trulicity, and Mounjaro.

Read more news on

Healthside-arrow

You may also like

Weight Loss Jab's Hidden Danger: Vision Loss Risk

1 day ago • 7 reads

article image

Weight Loss Drugs: The Hidden Physical Toll

4 Feb • 10 reads

article image

Weight Loss Drug Sparks Unexpected Pregnancies

1 Feb • 53 reads

article image

Ozempic Shrinks Wall Street: Tailors See Wardrobe Revolution

31 Jan • 60 reads

article image

Knock-off Weight Drugs: Deadly Risks Exposed

30 Jan • 76 reads

article image